Regentis Biomaterials Statistics
Total Valuation
RGNT has a market cap or net worth of $16.86 million. The enterprise value is $10.68 million.
| Market Cap | 16.86M |
| Enterprise Value | 10.68M |
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RGNT has 5.18 million shares outstanding. The number of shares has increased by 249.42% in one year.
| Current Share Class | 5.18M |
| Shares Outstanding | 5.18M |
| Shares Change (YoY) | +249.42% |
| Shares Change (QoQ) | +498.83% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.15% |
| Float | 3.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.67 |
| P/TBV Ratio | 3.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.65 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -88.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -107.53% |
| Return on Invested Capital (ROIC) | -178.48% |
| Return on Capital Employed (ROCE) | -146.88% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.96M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.49 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 28.30 |
| Average Volume (20 Days) | 8,083 |
Short Selling Information
The latest short interest is 19,319, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 19,319 |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 0.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.97M |
| Pretax Income | -13.65M |
| Net Income | -13.69M |
| EBITDA | n/a |
| EBIT | -6.97M |
| Earnings Per Share (EPS) | -$24.16 |
Balance Sheet
The company has $7.38 million in cash and $1.20 million in debt, with a net cash position of $6.18 million or $1.19 per share.
| Cash & Cash Equivalents | 7.38M |
| Total Debt | 1.20M |
| Net Cash | 6.18M |
| Net Cash Per Share | $1.19 |
| Equity (Book Value) | 4.74M |
| Book Value Per Share | 0.92 |
| Working Capital | 4.74M |
Cash Flow
| Operating Cash Flow | -1.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RGNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -249.42% |
| Shareholder Yield | -249.42% |
| Earnings Yield | -81.22% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |